Targeting the distal small intestine, specifically the terminal ileum, remains one of the greatest challenges in oral drug delivery.
Innovation in oral formulation technologies has opened new avenues for the lifecycle management and patent protection of biologics. Technologies such as SNAC, LBFs,…
In this webinar, Lonza Capsugel teamed up with sustainability innovators from HowGood and Puredia to share how brands can translate sustainability into supply…
The success and adoption of oral GLP-1 RAs mark a shift in biologic drug delivery. Technologies such as permeation enhancers, LBFs, and enteric protection have made…
Healthcare systems are facing increasing pressure as record demand, an aging population, the burden of chronic disease, and economic inflation challenge clinics,…
Meeting consumers’ needs is the first priority for any successful business. For over-the-counter (OTC) medications and supplements, oral dosage forms have long been…
Advancing acid labile or sensitive APIs is often slowed by coating steps that add time and complexity. This webinar offers a concise, science led look at recent data…
Discover how next-generation capsule technologies, including Capsugel(R) Enprotect(R) capsules, are advancing targeted oral drug delivery, improving bioavailability,…
The capsule market is shifting due to the growing importance of ethics and sustainability in driving consumer behavior. The ethical spending market has shown…
Maximizing Productivity in Vegan and Vegetarian Capsules Filling
A administração de modalidades biológicas biodisponíveis por via oral demanda conhecimento especializado em diversas áreas. Os cientistas e tecnólogos da Lonza Capsugel se dedicam a trabalhar com...
As terapias biológicas transformaram o tratamento de doenças crônicas e complexas, mas seu impacto é frequentemente limitado pela necessidade de administração parenteral...
A sustentabilidade está no cerne da nossa estratégia de negócios e filosofia operacional.
Entre em contato
Powered by Translations.com GlobalLink Web Software